| 注册
首页|期刊导航|国际妇产科学杂志|卵巢癌转移相关分子标记物及靶向性治疗药物的研究进展

卵巢癌转移相关分子标记物及靶向性治疗药物的研究进展

赵婷婷 沈国栋 胡卫平

国际妇产科学杂志Issue(4):457-460,4.
国际妇产科学杂志Issue(4):457-460,4.

卵巢癌转移相关分子标记物及靶向性治疗药物的研究进展

Research Progress of Ovarian Cancer Metastasis Related Molecular Markers and Targeted Therapy

赵婷婷 1沈国栋 2胡卫平1

作者信息

  • 1. 230001合肥,安徽医科大学附属省立医院妇产科
  • 2. 安徽省立医院老年病研究所
  • 折叠

摘要

Abstract

Ovarian malignant tumor is one of the three big malignant tumor in female reproductive system, the mortality rate is highest in gynecological tumors, which has become a serious threat to the female body health. According to the research of National Cancer Institute, ovarian cancer is one of the five female causes of death related to tumor. Epithelial ovarian cancer accounts for nearly 90%of all cases of ovarian cancer, and progress rapidly, but due to the lack of early clinical manifestations and specific symptoms, most are already late, when the patients see the doctors, surgery is difficult, and prognosis is poor. In recent years, there is an upward trend in the incidence of ovarian cancer, and it is easy to early metastasis and infiltration, which was the cause of the high mortality rate. Research on ovarian cancer metastasis of the malignant biological behavior has become a hot field. The early detection of effective ovarian cancer transfer related molecular markers and their targeted therapy is an important way to improve the survival rate of patients with ovarian cancer. In addition to the current clinical application of CA125 ,CD44,E-cadherin and ZEB1 is expected to become the molecular marker of early diagnosis of ovarian cancer metastasis.

关键词

卵巢肿瘤/肿瘤转移/肿瘤标记,生物学/治疗

Key words

Ovarian neoplasms/Neoplasms metastasis/Tumor markers,biological/Therapy

引用本文复制引用

赵婷婷,沈国栋,胡卫平..卵巢癌转移相关分子标记物及靶向性治疗药物的研究进展[J].国际妇产科学杂志,2015,(4):457-460,4.

国际妇产科学杂志

OACSTPCD

1674-1870

访问量0
|
下载量0
段落导航相关论文